Abstract
Toxin production in nematocysts by Cnidaria phylum represents an important source of bioactive compounds. Using electrophysiology and, heterologous expression of mammalian ion channels in the Xenopus oocyte membrane, we identified two main effects produced by the sea anemone Bartholomea annulata venom. Nematocysts isolation and controlled discharge of their content, revealed that venom had potent effects on both voltage-dependent Na+ (Nav) channels and GABA type A channel receptors (GABAAR), two essential proteins in central nervous system signaling. Unlike many others sea anemone toxins, which slow the inactivation rate of Nav channels, B. annulata venom potently inhibited the neuronal action potential and the Na+ currents generated by distinct Nav channels opening, including human TTX-sensitive (hNav1.6) and TTX-insensitive Nav channels (hNav1.5). A second effect of B. annulata venom was an agonistic action on GABAAR that activated distinct receptors conformed by either α1β2γ2, α3β2γ1 or, ρ1 homomeric receptors. Since GABA was detected in venom samples by ELISA assay at low nanomolar range, it was excluded that GABA from nematocysts directly activated the GABAARs. This revealed that substances in B. annulata nematocysts generated at least two potent and novel effects on mammalian ion channels that are crucial for nervous system signaling.
Similar content being viewed by others
Introduction
Cnidarians are a diverse group of aquatic invertebrate animals that include jellyfishes, corals, hydrozoans, and sea anemones, among some others1. Some cnidarians are considered highly venomous on humans (e.g. Refs.2,3,4). This characteristic is associated with the synthesis and assembly of microscopic and sophisticated bioweapons known as nematocysts5,6,7. These extraordinary structures, are essentially, capsules that contain venom and are endowed with penetrant spines that allow effective venom administration on demand. Nematocysts are produced in specialized cells named nematocytes5,8. The venom contains a mixture of compounds9 that includes proteinaceous (e.g., peptides, proteins, and enzymes) and non-proteinaceous (e.g., purines, quaternary ammonium compounds, biogenic amines, and betaines) substances10,11, with neurotoxic effects and cytolytic activity, among others12,13,14,15,16,17,18,19. Nevertheless, the complex cnidarian venomous apparatus is still not fully understood. Recent studies show that venom source is not restricted to nematocysts. For instance, distinct stinging-cell structures called cassiosomes have been identified in the Rhizotomies order (scyphomedusae Cassiopea xamachana)20, and sea anemones such as Nematostella vectensis or Anthopleura elegantissima have ectodermal gland cells that produce toxins21. Also, it has been shown that different toxins are expressed throughout the animal life span22, even more, different tissue types of a particular animal produce specific venom components23. The diversity of active substances contained in the nematocysts, and other cnidarian structures, encourages a constant search for novel, specific and potent toxins acting on vertebrate membrane proteins, especially from the nervous system. However, the number of species studied until now remains extremely low (about 4%1). In this search for toxins, two bottlenecks slow down new developments in the area; the first is the discovery of relevant effects and the identification of molecular targets of toxins, the second, is undoubtedly, the purification of toxins and determination of their chemical nature. In this study, we explore the toxicity of the sea anemone Bartholomea annulata venom and aim to determine some of its molecular targets.
Bartholomea annulata (Anthozoa:Actiniaria: Aiptasiidae: Metridiodea) is a common sea anemone that inhabits the Caribbean Sea24,25,26,27 and produces three different types of nematocysts: basitrichous isorhizas, microbasic p-mastigophores, and microbasic amastigophores26,28,29. It has also been reported that B. annulata venom has deleterious effects on crabs, fishes, and even mice, generating spasmodic convulsions, cardiac arrhythmia, paralysis, and death29,30. Nevertheless, the bioactivity of B. annulata venom, which might explain its potent lethality, has not been directly explored on nervous system membrane proteins, in fact, venoms from the Metridioidea superfamily have been studied only in a limited number of species, one of the most comprehensive studies shows effects of Exaiptasia diaphana toxins acting on ion channels expressed in cardiomyocytes31,32. In here, we analyzed electrophysiologically the effects of B. annulata venom on a library of membrane proteins (from rat brain) heterologously expressed in Xenopus oocytes through mRNA injection. Once possible novel targets were identified, the characterization of effects was refined using various preparations for their electrophysiological analysis. We demonstrate that B. annulata nematocysts contain substances that produce two effects observed for the first time in the actiniarian group: (1) It potently inhibits the current flux through voltage-dependent Na+ channels, both TTX-sensitive and TTX-insensitive channels, and (2) it acts as a GABAergic agonist activating GABA type A channel receptors (GABAAR). The importance of both effects, for the central nervous system functioning, strongly suggests that these substances are central in the lethality of B. annulata venom and indicates the production and delivery of novel toxins from sea anemones.
Results
Bioactivity
To test bioactivity of B. annulata (Fig. 1) venom, either crude sea anemone extract (AE) or crude extract isolated from nematocysts (NE; see below) was administered to Ocypode quadrata crabs (n = 4 for each case) injecting 15–20 µg of the extract per g/crab in 50 µl PBS. In all cases, strong alterations, including tremor of legs, chelas, and eyes, uncontrolled movements, variable periods of freezing that increased until causing total paralysis, and finally death. Crabs (n = 4) injected with vehicle did not present any response. All these alterations were compatible with effects on the neuromuscular system and confirmed previous observations29,33.
To conduct a broad screening of molecules involved in nerve transmission, we systematically analyzed the venom effect on membrane proteins from the rat brain that were heterologously expressed in Xenopus oocytes through mRNA injection15,33,34. It is well known that the oocyte has great experimental advantages for molecular target screening, including its capability to heterologously express functional proteins in its membrane that can be analyzed by electrophysiology. An example of the variety of electrical signals susceptible to analysis is shown in Supplementary Fig. S1. Using mRNA-injected oocytes, AE samples from B. annulata were tested. Figure 2 illustrates these experiments, first AE (0.1–1 mg ml−1) applied to control oocytes (H2O-injected; Fig. 2a) did not elicit any electrical response (n = 6, 3 frogs). However, AE application in oocytes expressing brain proteins generated several electrical responses (Fig. 2b–e), particularly three effects on three different responses were observed in all the oocytes tested. Thus, in oocytes held at − 60 mV, AE generated two types of currents that can be distinguished by their time-course (Fig. 2b) and their dependency on an intracellular Ca2+ concentration ([Ca2+]i) increase (Fig. 2c). These current responses are indicated as Is (smooth) and Iosc (oscillatory) in Fig. 2b. The first response, Is, was an inward current associated with an increase in membrane conductance. The second response, Iosc, began to increase a few seconds later and corresponded to an inward oscillatory current associated with an increase in conductance. Both responses, were co-activated while AE perfusion was maintained and were washed completely by NR superfusion. Iosc resembled the typical responses to various neurotransmitters when their receptors are expressed through brain mRNA injection in the oocyte (Fig. S135). These are currents dependent on [Ca2+]i increase promoted by phospholipase C activation and are due to Ca2+-dependent Cl− channels opening36,37. To explore if Iosc elicited by the extract was activated through the same mechanism, oocytes that generated Iosc by AE, were washed, loaded with EGTA38, and then tested again with AE (Fig. 2c, orange traces). In all cases, AE elicited only Is responses in EGTA-loaded oocytes, while Iosc were eliminated, indicating that Is was not Ca2+-dependent, and confirming that Iosc was more probably activated through [Ca2+]i increase. Iosc was the most robust response, whereas Is showed lower amplitude, reaching values of 93 ± 83 nA (n = 22) (orange bar graph in Fig. 2c). No further analysis was performed on the mechanisms of Iosc activation. To explore the basic characteristics of Is, its reversal potential (Erev) was estimated in EGTA-loaded oocytes that were held at distinct membrane potentials while AE was superfused (Fig. 2d). Is response had an Erev close to − 20 mV in all cases tested (3 oocytes, 2 frogs). Also, Fig. 2e illustrates experiments where a protocol of pulses from − 100 to + 40 mV (in steps of 20 mV) was applied in the absence (control) and presence of AE. Thus, the Is amplitude values elicited by AE in each potential were obtained by subtracting the corresponding control current values, and the results were plotted as illustrated. Is presented an Erev of − 22.7 ± 7.6 mV, like that obtained in Fig. 2d, suggesting a current mainly carried by Cl− ions36,39. In the responses elicited by the pulse protocol, a fast voltage-dependent inward current that desensitizes within a few milliseconds was regularly activated (green circle in Fig. 2e; see also Supplementary Fig. S1). This current (denoted as INav) corresponds with the opening of voltage-dependent Na+ channels commonly expressed in brain mRNA-injected oocytes40,41. As depicted in Fig. 2e, INav appears to be inhibited during the application of AE. Based on this initial screening, we decided to characterize in detail the AE effects on Is activation and INav inhibition.
Inhibition of I Nav
AE was applied to mRNA-injected oocytes expressing INav to quantify its effect within a potential range of − 100 mV to + 40 mV and explore its reproducibility in different preparations. The peak INav amplitude at − 20 mV was inhibited 96.5 ± 4.97% by 1 mg ml−1 AE (7 oocytes, 3 frogs, Fig. 3a–c). However, the extract at 0.1 mg ml−1 still caused a potent inhibition of 70.8 ± 15.89% (18 oocytes, 7 frogs). AE samples boiled for 45 min fully maintained their inhibitory activity (7 oocytes, 3 frogs), indicating that the inhibitory substance was thermostable (Fig. 3b).
INav kinetics monitored in the oocyte, within the entire range of potentials tested, results uncertain due to the oocyte size. Due to this, and to explore the effect of AE on endogenous molecules (i.e., INav in neurons), the following experiments were performed using cultured rat cortical neurons. Figure 3c shows the I–V relationships for INav generated either in mRNA-injected oocytes or in neurons, and for both cases in the absence (black circles) and the presence (green circles) of AE; it was found that inhibition by AE was similar in both preparations. Thus, INav inhibition occurred in the entire range of membrane potentials and, importantly, AE had the same effect on neurons; for example, 0.1 mg ml−1 AE inhibited neuronal INav by 95.3 ± 3% (5 cells). Figure 3d illustrates a typical example of neuronal INav elicited by 20 ms voltage steps within the − 10 to − 40 mV range from a holding potential of − 100 mV, regularly, the maximum current amplitude was obtained at − 20 mV. To study the time-course of the effects of AE, and other treatments, pulses to − 20 mV were repeated every 0.75–1 s for several seconds (70–85 s; Fig. 3d) in such a way that the different treatments were applied for 5–10 s after a control period, followed by washing with external solution. The insert in 3d illustrates a series of control responses obtained using this protocol that have been superimposed to show INav reproducibility, the time scale corresponds to that of a single depolarizing pulse. Typical results testing the effect of different treatments using this protocol were illustrated with superimposed traces as it is shown in Fig. 3e, where the time-course INav inhibition by AE was analyzed by depolarizing the neurons from − 100 mV as described, after 10–12 voltage steps in control external solution (black traces) AE was superfused for 5–10 s (green traces) and the effect on INav was monitored. Finally, AE was washed and INav recovery followed for several seconds (traces in black). As this is shown in the bottom graph, application of 0.1 mg ml−1 of AE produced INav inhibition with a τ50 of 2.88 ± 0.03 s (Fig. 3f, green circles; 5 neurons), while smaller outward currents activated at this potential were not significantly affected (yellow circles; most likely corresponding to voltage-gated K+ channels). Recovery of inhibition required, in most cases, a 30–45 s wash. During INav inhibition produced by AE, no change in the current inactivation rate was observed. For example, in a group of neurons (n = 6) the control time constant of inactivation was of 0.97 ± 0.48 ms, while after 3 s in the presence of AE (0.1 mg ml−1), time in which more than 50% of INav inhibition was regularly reached, this parameter was of 1.13 ± 0.7 ms. These values did not show a statistical difference.
All the experiments described above used AE, the homogenate of B. annulata. Although it is known that this method successfully discharges nematocysts, the venom obtained with AE clearly may include substances from other anemone tissues in addition to the nematocysts content per se (e.g. Ref.20) To confirm that effects were elicited by nematocysts content, a procedure for nematocysts isolation was done followed by controlled discharge through mechanical means. Figure 4a shows the sea anemone homogenate visualized using phase contrast microscopy. This sample contained a large number of nematocysts, together with symbionts and the sea anemone tissue itself. Comparatively, using a modified Bloom’s method42, and settling periods of 24–48 h (Fig. 4b) provided with nematocysts free samples of most of other animal tissue, also significantly reduced the number of symbionts. An amplification of these preparations showed the typical morphology of loaded nematocysts containing twisted tubules in their lumen (arrows, Fig. 4c). The purified nematocysts samples obtained after 24–48 h were then pressed to 6.2 × 107 Pascals using a French press. The extract obtained will be referred to as nematocysts extract (NE). The pressed preparations were then visualized under the microscope (Fig. 4d,e) to quantify the number of loaded and unloaded nematocysts after 24–48 h (Fig. 4f). Under the microscope, nematocyst discharge was visualized as an empty capsule associated with a large ejected tubule (asterisks and arrows, respectively in Fig. 4e). Figure 4f is a quantification made by triplicate of undischarged (gray bars) or discharged (green bars) nematocysts, in non-pressed aliquots compared with pressed aliquots from the same anemones samples. Quantification showed that in both 24-h and 48-h groups the efficiency of total nematocysts recovery increased, and that a small proportion of non-pressed nematocysts were already discharged. More importantly, it revealed that pressing led to a significant nematocysts discharge. For instance, from a total of 1190 ± 144 nematocysts per μl after 48 h of incubation, the pressed sample rendered 1096 ± 130 discharged nematocysts per μl; thus, most nematocysts were discharged after being pressed.
The time-course and potency of the effect for both AE and NE on neuronal INav, using the protocol as in Fig. 3d–f, is shown in Fig. 4g,h. First, 1 mg ml−1 AE inhibited INav by 77.9 ± 12.6%, while NE (1 mg ml−1) obtained from the same anemones batch, incubated for 24 or 48 h, inhibited INav by 56.8 ± 5.2% (light green circles) and 69.4 ± 4.4% (dark green circles), respectively (Fig. 4h). Both NE samples showed lower inhibition amplitude with a slower time-course compared to AE; however, the inhibitory effect was similar. The 48-h non-pressed (gray circles) sample presented low activity on INav (peak inhibition of 9.2 ± 4.7%). Altogether, these data strongly suggested that the effect on INav was due to a substance or substances contained in the nematocysts of B. annulata.
As a first approach for separation and purification of the toxins responsible for the effects, chromatography was performed with a Sephadex G-50 M column that allows substances separation based on their molecular weight. Chromatographic pattern from AE separated three peaks that were identified as FI, FII and FIII fractions (Fig. 5a). The bioassay of these fractions (Fig. 5b) on neuronal INav indicated that 1 mg ml−1 FI did not affect INav, while FII was a potent fraction reaching inhibition values of 99.82 ± 0.47%. FIII also showed activity reaching an inhibition of 79.5 ± 25.9%, although its effect exhibited greater dispersion. The inhibitory time-course by FII was like that observed with AE and NE (Fig. 5b).
Since FII and FIII elicited INav inhibition, a chemical analysis using MALDI-TOF mass spectrometry was done as this is shown in Fig. 5c. Both fractions showed peptides with molecular masses between 3 and 12 kDa, however, FII was more complex in composition than FIII. Importantly, the molecular masses observed were in the range of those reported for sea anemone neurotoxins (3–7 kDa)6. The presence of apparently equivalent components, in FII (e.g., m/z 5914.34 and 12,382.10) and FIII (m/z 5911.56 and 12,368.31) (Fig. 5c), might be an explanation for similar effects in both fractions.
The sensitivity of INav to FII clearly presented a dose–response (D-R) relationship with a mean dose of 80.4 ± 16 μg ml−1 (Fig. 5d). Also, FII was used to analyze in cultured neurons its effect on action potential generation. For this, constant current pulses (0–65-0.85 nA) were applied to generate action potentials every 1–1.2 s at 30% above threshold amplitude, to avoid failures in impulse generation. Then, different solutions containing 10 μg to 1 mg of FII were applied for 10 s (n = 4, Fig. 5e). Complete action potential inhibition was observed in a dilution as low as 0.05 mg ml−1 after 3–4 s of superfusion, while a robust inhibition effectiveness was observed from 0.1 to 1 mg ml−1. FII produced a fast action potential blockage, and the duration was not affected during FII application. At all concentrations tested, the recovery of action potential amplitude was complete after washing.
Tetrodotoxin (TTX) is a potent Nav channel blocker43, the molecular identity of the TTX binding site on the channel is well known44. To know whether NE inhibition effect was produced acting on the same or similar TTX binding site, extract was tested in HEK293 cells expressing either hNav1.6 or hNav1.5 channels. As it is well known, TTX acts differentially on distinct INav subtypes; hNav1.6 is a TTX-sensitive channel, whereas hNav1.5 is essentially a TTX-insensitive channel45. INav currents in HEK cells were recorded similarly to those in neurons; thus, current responses were activated by depolarizing the cell periodically to values around the peak current. As is illustrated in Fig. 6a,c, 1 mg ml−1 NE superfusion inhibited the current elicited by hNav1.6 opening as strongly as the blockage produced by 50 nM TTX (Fig. 6b,c). Remarkably, 1 mg ml−1 NE also strongly inhibited the current generated by hNav1.5 channel activation (Fig. 6d,f). As expected, in these same cells the INav current was not blocked by TTX (Fig. 6e,f). Also, comparing the rates of inhibition and recovery of NE and TTX on the hNav1.6 current, NE seemed to act faster than TTX, and 155 ± 34 μg ml−1 NE inhibited 50% of INav (Fig. 6g). Like that observed with AE, NE (1 mg ml−1) either boiled for 15 min or incubated for 24 h at 37 °C, fully retained activity (Fig. 6h).
Generation of I s response and GABAA receptor activation
AE consistently generated a smooth inward current (Is) associated with an increase in membrane conductance in mRNA-injected oocytes (Fig. 2b–e). This response was generated in both neurons and oligodendrocytes, although the amplitude response was clearly weaker in the latter cell type, as illustrated in Fig. 7a. In oocytes, the estimated Erev corresponded with the flux of Cl−; thus, the I–V relationship for the inward response was built for neurons (Fig. 7b). We also found that the Erev for the inward current response in external solution containing 146 mM Cl− was of − 8.8 ± 3.5 mV, while in solution with reduced Cl− concentration (36.5 mM) the Erev shifted to a potential of + 16.2 ± 4.3 mV, and the inward current amplitude became larger; altogether, these results suggest that inward current response was mainly carried by Cl−. The main Cl− channel in neurons is GABAAR. To explore a possible GABAAR involvement in the response elicited by AE, the extract was coapplied in neurons with either 30 μM bicuculline or picrotoxin, an antagonist and a blocker of the GABAAR, respectively. In neurons (Fig. 7c–e; 5–7 neurons), bicuculline inhibited to 19 ± 18.1% the current elicited by 30 μM GABA, whereas picrotoxin blocked around 50% of the GABA response (to 48.2 ± 7.6%). In the same neurons, bicuculline and picrotoxin inhibited the current activated by 0.5 mg ml−1 AE to 57.5 ± 24.4% and 52.2 ± 12.8%, respectively (Fig. 7e). Contrary to what was observed in the GABA-generated current, bicuculline had a more variable effect on the inward current elicited by AE (see Fig. 7c), although picrotoxin presented a similar blocking effect either with GABA or AE stimulation (Fig. 7d).
The FI-FIII fractions obtained by chromatography also showed differential potency on neurons, thus 1 mg ml−1 FI was ineffective (7 neurons) to generate the inward response, 1 mg ml−1 FII generated inward responses of 1128 + 763 nA (13 cells), while FIII generated weak responses of 170.3 + 112 nA (7 cells), suggesting that the effect was elicited for a substance mainly contained in fraction FII.
To confirm a direct action on GABAAR by AE and NE, receptors were expressed in oocytes. Expression of the most common neuronal GABAAR, comprised by α1β2γ2 subunits, provides sensitivity to GABA superfusion (Fig. 8a). Oocytes responding to 10 μM GABA were also sensitive to 0.5 mg ml−1 AE superfusion, generating smooth inward currents that opened rapidly after beginning the application and stayed activated until GABA or AE were washed out. To make the application of AE more efficient, the extract was applied through a jet of solution ejected close to the oocyte surface. Extract solution jet application was a reproducible method of stimulation that consumed minimal amount of venom (Fig. 8a). The AE jet application method did not generate any response in native oocytes (Fig. 8b); however, in oocytes expressing the neuronal GABAAR, the delivery of either AE or NE prompted a rapid inward response that, as expected, had an Erev of − 22.8 ± 2.6 mV (Fig. 8c). GABAARs composed of other subunits expressed in oocytes were also activated by AE and by NE applied in similar manner; thus, receptors comprised by α3β2γ1 subunits typically expressed in oligodendroglial cells46 and homomeric ρ1 GABAR47 were also operated by the extracts. The α3β2γ1 receptor has an EC50 for GABA of 80 μM, with a threshold for the response close to 1 μM (Fig. 8d, red traces). The typical neuronal receptor expressed in the oocyte membrane has an EC50 around 100 μM with a threshold also close to 1 μM, while the homomeric GABAAR ρ1 has an EC50 of 1.2 μM, with a threshold within the nanomolar range (Fig. 8d, green traces). Using the same conditions and micropipette for jet application, responses to AE had an expected amplitude for the respective GABAAR expressed; thus, α3β2γ1-receptor responses were lower in amplitude, while ρ1-receptor responses were consistently larger (Fig. 8e).
These results suggested that extracts could contain GABA at a concentration within the micromolar range; thus, AE samples were analyzed using a GABA-specific ELISA test (with nanomolar detection sensitivity). However, AE and NE samples (3 different extracts) that activated robust responses in oocytes expressing either the α1β2γ2- or the α3β2γ1-receptor reported a GABA concentration of 9.97 ± 1.8 nM in the ELISA test, which by itself did not explain the observed amplitude responses. This strongly suggested that B. annulata venom contained a potent GABAAR agonist different to GABA.
Discussion
More than sixty toxins affecting Nav channels have been isolated from sea anemones, most of them cause a delay in Nav channel inactivation48,49. The results described here show two novel toxic effects exerted by substances contained in the nematocysts of the sea anemone B. annulata, each one acting on fundamental membrane proteins of the mammalian nervous system: the Nav channel and the GABAAR. The recognition of species of interest, due to specific effects of their toxins and/or by their venom potency, is undoubtedly an advantage to direct the search for new bioactive principles. Here we show that B. annulata venom contains substances that act on the nervous system of both vertebrates and invertebrates, as seen by the effects on crabs and on membrane proteins of vertebrates, specifically those from the nervous system of mammals (including human). The novelty of the effects described here, clearly indicates the importance of studying the potential bioactivity of cnidarian families that remain unexplored.
In several experiments of this study, nematocysts of B. annulata were first isolated using a modified Bloom’s method42, and then subsequently discharged in a controlled manner, applying pressure conditions that did not affect the symbiont structural integrity, as previously reported50. This increased the certainty that the effects observed were generated by compounds contained in the nematocysts, since extracts that were not pressed had reduced activity compatible with the basal discharge observed by nematocysts quantification.
Nav and GABAAR channels are crucial in neural functions and effects on them could explain by themselves the venom lethality30,51,52. Nav channels are responsible for nerve impulse generation, while GABAARs are important effector molecules of GABA, the main inhibitory neurotransmitter in the nervous system. Until now, most neurotoxins isolated from sea anemones (e.g., ShK, BgK, CgNa, and CGTX II) affect Kv or Nav channels13,53,54,55,56,57,58,59. The peptide neurotoxins that act on Nav channels are widely studied and have been classified into four types6. It is known that the action mechanism of many toxins from anemones involves their binding to open Nav channels, causing a delay in channel inactivation and an increase in action potential duration57,60,61. However, different to this mechanism, our results showed that B. annulata venom contains a substance that inhibits the Nav current response at the whole voltage range tested, without affecting both the inactivation rate, and apparently neither the voltage dependency of activation. Also, INav inhibition more probably caused a rapid and dose-dependent blockage of the action potential generation in cortical neurons with no effect on its duration, suggesting that the inhibitory effect of B. annulata venom was more compatible with a blockage of the Nav channel pore, although a complete definition of the inhibition mechanisms involved will require of further experiments. The chemical identity of the toxin(s) remains to be elucidated; however, it would correspond to a heat-stable molecule of more than 3000 Da. These features agree with the results of mass spectrometry analyses of FII and FIII that showed the presence of peptides in the expected range. Thermostability of anemone toxins has been reported in several cases and, this characteristic has been associated with the stability provided by the presence of disulfide bridges in its structure (e.g., Refs.6,51,62). It is also evident that its action mechanism was not identical to that of TTX, because B. annulata venom inhibited both the human Nav1.6 and Nav1.5 channel current responses, which clearly differ in their sensitivity to TTX45,63. It is still possible that B. annulata bioactive substance, described here, shares an overlapping binding site with TTX, and some small change in Nav1.5 is enough to interfere with TTX and not with that of B. annulata.
A different binding site for pore blockage in Nav channels is that of the cone snail toxin GIIIA64, more experiments will be necessary to establish its possible participation in the B. annulata venom effect. The functional study of new molecules that affect Nav channels in mammals remains limited. Hence, the discovery of new template molecules that could act in a more specific and differential manner is of general interest for the design and development of novel molecular tools (e.g. Ref.65). Furthermore, Nav channels regulation are important not only for nervous system physiology but also because of their possible role in various diseases including cancer66,67,68,69.
A second molecule in the venom, acting as a GABAergic agonist, also represents a new action mechanism for sea anemone toxins, and its rapid action opening the channel in the millisecond range, as well as the complete recovery upon wash, resembles the action of the full agonist muscimol produced by the fungus Amanita muscaria70. Several natural substances act on GABAAR and many are drugs that have powerful effects on the nervous system (e.g., picrotoxine, β-carbolines). Also, peptides that inhibit GABAARs have been previously described in marine animal venoms in at least two species, Laticauda semifasciata and Conus imperialis71. In the case of B. annulata venom, the active substance operated three GABAAR types with different molecular identities (either neuronal or glial heteromeric receptors, as well as the ρ1 homomeric receptor); thus, this suggested that the venom contained concentrations in tens of the micromolar range of GABA. The expression of the GABAergic signaling system has been documented in cnidarians where it has been related to nematocyst discharge regulation, among other functions72. However, results of ELISA assays with sensitivity to nanomolar GABA concentration showed that the venom contained GABA in around 10 nM. This indicated that the molecule responsible for GABAAR activation was of a different nature since this concentration was too low to activate either the neuronal or the oligodendroglial receptor. Alternatively, the venom could contain a potent positive modulator that would increase the GABAAR sensitivity to GABA.
Nevertheless, our results also suggested that GABAARs were not the only receptors activated by the venom. Thus, testing the venom on cortical neurons revealed that currents produced in some cells, persisted even after its co-application with bicuculline, a potent competitive antagonist of the GABA site. This finding could also be explained by a different competition mechanism between bicuculline with the active substance as compared with GABA. On the other hand, the importance of a molecule in the venom that depresses the activity of the central nervous system seems to be clear, and it is striking that this mechanism apparently is not common among the venoms studied so far, since combining it with a powerful Nav channel blocker molecule would result in a fast-acting bioweapon.
The advancement of robust biochemical and molecular techniques will provide detailed information about the identity of substances contained in the venom of many species that remain unexplored, including cnidarians. This study showed that the common Caribbean B. annulata is a source of novel neurotoxins that potently target essential proteins for the functioning of the mammalian central nervous system.
Conclusion
The number of marine species that synthesize bioactive molecules studied is far from being exhausted, these molecules are widely diverse, and their molecular targets are of great interest in terms of basic mechanisms and for the development of new therapeutic and experimental tools. The use of heterologous expression models for the recognition of target molecules, such as the expression in X. laevis oocytes, represents a useful method to recognize relevant effects of the venoms. Here, oocytes expressing mammalian brain ion channels and membrane receptors revealed effects of the B. annulata venom on two of the most important proteins for the functioning of the nervous system, Nav channels and GABAARs.
Materials and methods
Animal ethics declarations
All animal studies complied with the ARRIVE guidelines. All the animals were treated with the utmost care to minimize their suffering and were handled in accordance with the Guide for the Care and Use of Laboratory Animals by the USA National Institutes of Health, as well as the Local Guidelines on the Ethical Use of Animals for Experimentation at the Universidad Nacional Autónoma de México. B. annulata sample collection was carried out through permit no. PPF-066/20 from Dirección General de Ordenación Pesquera y Acuicultura, Quintana Roo, México.
Sea anemone collection and venom extraction
Specimens of Bartholomea annulata were collected from the reef lagoon at Puerto Morelos, Quintana Roo, México (20° 50′ 45″ N 86° 52′ 08″ W; 20° 50′ 55″ N 86° 52′ 52″ W) by SCUBA diving (Fig. 1).
The venom extracts were prepared using two different methods, as follows: (1) Sea anemone macerate to obtain AE was carried out as described elsewhere29. Briefly, whole sea anemone bodies were homogenized in deionized water to perform the nematocysts discharge. Rupture of nematocysts was monitored by microscopy until most nematocysts were discharged. The extract obtained was centrifuged at 3.2 × 103×g at 4 °C for 10 min, the supernatant was decanted, and the same procedure was applied one more time. Finally, the supernatant was dialyzed using a pore size limit of 3000 Da, lyophilized and frozen until it was used. (2) Nematocyst’s isolation and discharge to obtain NE. To avoid contamination of the extract with other cells or tissues, sea anemones were washed with filtered (0.45 µm) sea water to remove sand and small stones57, then they were exposed to six freeze–thaw cycles. Sea anemone bodies were immersed in two volumes of distilled water kept at 4 °C and stirring every 10 min for 2 h (modified from Ref.42). Samples were filtered with a 100-µm-mesh and the filtered material was allowed to settle for either 24 h or 48 h. After the settlement period the sediment was washed three times, first with phosphate buffer solution (PBS, containing in mM: 2.74 NaH2PO4, 7.2 dibasic Na2HPO4) plus 0.01% Triton, and then twice with PBS alone. The precipitate was visualized under a microscope to monitor the number of undischarged nematocysts. Then, discharge of these organelles was carried out applying a pressure of 6.2 × 107 Pa using a French press cell disruption homogenizer (SLM-AMINCO, Urbana, IL, USA). It has been reported that symbionts are affected applying a higher pressure of 8.3 × 107 Pa50. Finally, samples were centrifuged at 105 g for 1 h at 4 °C, and the supernatant containing the venom was dialyzed using a pore size limit of 3000 Da, lyophilized, and kept at − 30 °C.
Toxicity test
Both extracts were tested in Ocypode quadrata crabs, collected from the Puerto Morelos beach. Aliquots (50 μl) of either extract dissolved in PBS, or PBS alone as a control, were injected through the third walking leg29,33.
Size exclusion chromatography
The AE was fractionated using Sephadex G-50 M. The column was equilibrated with PBS. Samples dissolved in the same buffer were eluted to a flow rate of 300 μl min−1, with monitoring at 280 nm, and 5-ml fractions were collected. The fractions were concentrated with reduced pressure (“rotary evaporator”), dialyzed using a pore size limit of 3000 Da, and lyophilized.
Mass spectrometry
Fractions FII and FIII were chemically analyzed using MALDI-TOF mass spectrometry. 5 μl of a saturated solution of sinapinic acid (> 99.0% purity for MALDI-MS, Sigma, St. Louis, MO, USA) were added to 5 μg of lyophilized of each fraction. 1 μl of this solution was deposited onto the MALDI plate and allowed to dry at room temperature. The spectrum was recorded on linear positive mode on a mass spectrometer (Microflex Bruker Daltonics, Bremen, Germany) equipped with nitrogen laser λ = 337 nm and a 20 kV acceleration voltage.
mRNA and cDNA
The poly(A)-mRNA was purified from adult Wistar rat brains; for this, mRNA was extracted from the whole brain using the guanidinium/phenol/chloroform method followed by oligo(dT)-cellulose chromatography73. The mRNA pool used here was purified from 19 different extractions from the same number of brains, each extraction was analyzed for its quality by electrophoresis and the ratio of absorbance 260/280 nm, as well as for its expression capacity of ion channels and membrane receptors into oocytes from different frogs. It was dissolved to 1 ng nl−1 in water and stored at − 80 °C until its use for expression using Xenopus oocytes.
The cDNA coding sequences for α1, α3, β2, γ1, and γ2 subunits of the GABAAR were obtained as previously reported46 from neural tissue, while ρ1 subunit coding sequence was donated by Dr. Ataúlfo Martínez-Torres47. All subunits were amplified, and each fragment obtained was cloned into pXENEX1 vector at the Ncol, BamHI, and NotI sites, then plasmids were linearized with the Hind III enzyme and used as templates for cRNA in vitro synthesis using the T7 mMESSAGE mMACHINE kit following the standard protocol (Ambion Invitrogen, Grand Island, NY, USA). cRNA was dissolved to 0.1 ng nl−1 in water and used for heterologous expression in Xenopus laevis oocytes.
Heterologous expression in Xenopus oocytes and electrophysiology
Oocytes at stages V and VI74 were dissected from ovary lobules of Xenopus laevis and microinjected either with 50 nl of mRNA (1 ng nl−1) purified from rat brain or 50 nl of solution containing GABAA cRNA (5 ng per oocyte)75. After 48 h, the injected oocytes were treated with collagenase (0.5 mg ml−1) at room temperature for 30 min in normal frog Ringer’s (NR) solution (containing in mM: 115 NaCl, 2 KCl, 1.8 CaCl2, 5 HEPES, pH 7.0)15. Finally, oocytes were kept at 16–18 °C in sterile normal Barth´s solution (containing in mM: 88 NaCl, 1 KCl, 2.4 NaHCO3, 0.33 Ca (NO3)2, 0.4 CaCl2, 0.82 MgSO4, 5 HEPES, supplemented with 70 µg ml−1 gentamycin, pH 7.4) until they were used for electrical recordings.
Two or more days after injection, the membrane currents were recorded using the two- electrode voltage-clamp technique38. Microelectrodes (1 MΩ) were inserted into the oocyte and transmembrane currents were monitored using an Axon GenClamp 500 B (Molecular Devices, San Jose, CA, USA) amplifier. Signals were digitized and stored using an analog-to-digital convertor (Axon DigiData 1200; Molecular Devices) and specialized software (pClamp v9; Molecular Devices)75.
Unless otherwise stated, oocytes were held at − 60 mV and continuously superfused (10 ml min−1) with NR. The venom and distinct neurotransmitters (serotonin, 5 HT; γ-aminobutyric acid, GABA; acetylcholine; glutamic acid) were applied regularly by superfusion. To activate voltage-dependent ionic channels, mainly Nav channels, a protocol of voltage steps was applied to build the current–voltage (I–V) relationships. Voltage-step protocols were applied while oocytes were held at − 100 mV and membrane potential was changed from − 80 to + 40 mV in steps of 20 mV for 250 ms, current responses were measured either at the steady-state or at the peak of the inward current, for Is response or INav, respectively.
Injection of 500 pmol ethylene glycol-bis(β-aminoethylether)N,N,N′,N′,-tetraacetic acid (EGTA) into oocytes was made by pneumatic pressure ejection from micropipettes containing 200 mM EGTA solution (plus 5 mM HEPES, adjusted to pH 7.0 with KOH)38.
The method of drug application by superfusion regularly requires of a high sample volume (10 ml per min of application) for oocyte recording. Here, a much more efficient delivery system for the extracts was used (Fig. 8). This method consisted of applying the extract sample, either AE or NE (in NR solution), through jets of solution from a micropipette placed near the surface of the oocyte (approximately 100 μm), while maintaining the general flow of the external medium at a minimum level of 0.5 ml min−1; then the extract contained in the micropipette was ejected by applying small pulses of pressure through the opposite end. The pressure (regularly 10–20 PSI) was controlled through a manometer as well as by modifying the pulse duration. In this manner small volumes of test solution were applied. Regularly jets of few nanoliters (25–100 nl) were enough to activate current responses in oocytes expressing GABAARs.
Electrophysiology and culture of neural cells and HEK293 transfected cells
Primary culture of neurons was obtained from E18 Wistar rat embryos according to previously described procedures76. Briefly, neurons derived from cortical lobes were resuspended in B27 neurobasal medium plus 10% Fetal Bovine Serum (FBS) and then seeded onto poly-l-ornithine-coated (30 µg ml−1) 24-well plates bearing 12-mm-diameter coverslips at 1 × 103 cells per well. The medium was replaced by serum-free B27-supplemented Neurobasal medium 24 h later. The cultures were essentially free of astrocytes and microglia and were maintained at 37 °C and 5% CO2. Cultures were used at 7–12 days in vitro (DIV).
Primary cultures of oligodendrocytes derived from optic nerves of 12-day-old Sprague–Dawley rats were obtained as described previously77,78. Cells were seeded on 24-well plates bearing 12-mm-diameter coverslips coated with poly-d-lysine (10 mg ml−1) at a density of 104 cells per well. Cells were maintained at 37 °C and 5% CO2 in Sato medium70 and recorded from 1 to 2 DIV.
Also, venom extracts were tested on HEK293 (human embryonic kidney) cells expressing human Nav channels (hNav 1.5 or hNav 1.6), donated by Dr. Rita Restano Cassulini79. Cells were incubated in Dulbecco’s modified Eagle medium (DMEM) with 10% FBS and antibiotic G418 (400 µg ml−1), at 37 °C with 5% CO2.
Whole-cell patch-clamp recordings of either neural or HEK293 membrane ionic currents were performed with an Axon 700B amplifier (Molecular Devices). Cells were constantly perfused with normal external solution (NES, containing in mM: 135 NaCl, 5 KCl, 2 CaCl2, 1 MgCl2, 10 HEPES, and 5 glucose adjusted at pH 7.3 with NaOH). The pipette was filled with normal internal solution (NIS, containing in mM: 5 NaCl, 130 KCl, 1 CaCl2, 1.8 MgCl2, 10 HEPES, 10 EGTA, 0.2 Na-GTP, and 2 Mg-ATP at pH 7.3 (KOH). Data were digitized at 5 kHz and low-pass filtered at 0.5 kHz. Currents were recorded at distinct holding membrane potentials depending on the experiment as specified in each case, digitized, and stored for analysis using the analog-to-digital converter Digidata 1400 (Molecular Devices) and pClamp10 software (Molecular Devices). Current–voltage (I–V) relationships were regularly built by changing the membrane potential from − 100 to + 40 mV in 10-mV steps of 250 ms while cells were held at − 100 mV. In some instances, cells were held at a desired membrane potential while a test solution was superfused or applied using the jet method, and the peak currents generated were I/V plotted. Time-courses of the effect on INav were followed in cells held at − 100 mV and then depolarizing steps (20 ms) eliciting maximal current (usually to − 20 mV or − 10 mV) were applied periodically every 0.75–1 s. Usually, the control current was monitored for 10 s and then a test solution was superfused for 5–10 s to record the effect on INav, this was followed by a washing period with NES.
In one set of experiments the action potential was recorded in neurons under current-clamp, in these cases depolarizing current pulses (0.65–0.85 nA) of 35 ms were applied to generate action potentials every 500 ms, after a recording period control, different dilutions of FII were applied to test their effect on the nerve impulse.
Dose–response curves were fitted to the equation:
by the method of nonlinear least-squares fitting, where EC50 is the half-maximal effective concentration for the extract, nH is the slope factor (Hill coefficient), A1 and A2 are the initial and final normalized current (I) values, respectively, and [extract] is the concentration of either FII or NE.
ELISA for GABA
GABA detection in both AE and NE was assayed using GABA ELISA Kit (Aviva Systems Biology, San Diego, CA, USA) according to the protocol instructions. Briefly, titrated standards and diluted samples were placed in a microtiter well-plate previously pre-coated with an anti-GABA antibody. GABA-Biotin complex was added to each well and the plate was incubated for 60 min. After incubation, the plate was washed. Avidin-HRP conjugate was added to each well and incubated for 45 min. Finally, 3,3′,5,5′-Tetramethylbenzidine (TMB) substrate was incubated for 30 min. Samples were read at 450 nm on an ELISA standard microplate reader.
Statistical analysis
All data are expressed as mean ± S.D. of at least 4 cells, and in the case of oocytes, cells were obtained from 2 to 7 different frogs. The means of two groups were compared using a Student's t-test, or when appropriate, by analysis of variance followed by post-hoc comparisons of individual means using the Bonferroni correction. Statistical analysis was performed using GraphPad Prism software (version 6; La Jolla, CA). Differences were considered to be significant at p < 0.05.
References
Santhanam, R. Biology of Marine Cnidarians [Phylum Cnidaria (= Coelenterata)]. In Biology and Ecology of Venomous Marine Cnidarians (ed. Santhanam, R.) 7–27 (Springer, 2020).
Brinkman, D. L. et al. Venom proteome of the box jellyfish Chironex fleckeri. PLoS ONE 7, e47866 (2012).
Diaz-Garcia, C. M. et al. Toxins from Physalia physalis (Cnidaria) raise the intracellular Ca2+ of beta-cells and promote insulin secretion. Curr. Med. Chem. 19, 5414–5423 (2012).
Remigante, A. et al. Impact of scyphozoan venoms on human health and current first aid options for stings. Toxins 10, 133–151 (2018).
Fautin, D. G. Structural diversity, systematics, and evolution of cnidae. Toxicon 54, 1054–1064 (2009).
Honma, T. & Shiomi, K. Peptide toxins in sea anemones: Structural and functional aspects. Mar. Biotechnol. 8, 1–10 (2006).
Morabito, R., Marino, A. & La Spada, G. Nematocytes’ activation in Pelagia noctiluca (Cnidaria, Scyphozoa) oral arms. J. Comp. Physiol. A 198, 419–426 (2012).
Beckman, A. & Özbek, S. The nematocyst: A molecular map of the Cnidarian stinging organelle. Int. J. Dev. Biol. 56, 577–582 (2012).
Jouiaei, M. et al. Ancient venom systems: A review on Cnidaria toxins. Toxins 7, 2251–2271 (2015).
Frazão, B., Vasconcelos, V. & Antunes, A. Sea anemone (Cnidaria, Anthozoa, Actinaria) toxins: An overview. Mar. Drugs 10, 1812–1851 (2012).
Madio, B., Undheim, E. A. B. & King, G. F. Revisting venom of the sea anemone Stichodactyla haddoni: Omics techniques reveal the complete toxin arsenal of a well-studied sea anemone genus. J. Proteom. 166, 83–92 (2017).
Béress, L. & Béress, R. Purification of three polypeptides with neuro- and cardiotoxic activity from the sea anemone Anemonia sulcata. Toxicon 13, 359–367 (1975).
Castañeda, O. et al. Characterization of a potassium channel toxin from the Caribbean sea anemone Stichodactyla helianthus. Toxicon 33, 603–613 (1995).
Bruhn, T. et al. Isolation and characterization of five neurotoxic and cardiotoxic polypeptides from the sea anemone Anthopleura elegantissima. Toxicon 39, 693–702 (2001).
Torres, M. et al. Electrophysiological and hemolytic activity elicited by the venom of the jellyfish Cassiopea xamachana. Toxicon 39, 1297–1307 (2001).
Anderluh, G. & Maĉek, P. Cytolitic peptide and protein toxins from sea anemones (Anthozoa: Actinaria). Toxicon 40, 111–124 (2001).
Marino, A., Morabito, R., Pizzata, T. & La Spada, G. Effect of various factors on Pelagia noctiluca (Cnidaria, Scyphozoa) crude venom-induced haemolysis. Comp. Biochem. Physiol. A Mol. Integr. Physiol. 151, 144–149 (2008).
Lazcano-Pérez, F. et al. A purified Palythoa venom fraction delays sodium current inactivation in sympathetic neurons. Toxicon 82, 112–116 (2014).
Morabito, R. et al. Crude venom from nematocysts of Pelagia noctiluca (Cnidaria: Scyphozoa) elicits a sodium conductance in the plasma membrane of mammalian cells. Sci. Rep. 7, 41065 (2017).
Ames, C. L. et al. Cassiosomes are stinging-cell structures in the mucus of the upside-down jellyfish Cassiopea xamachana. Commun. Biol. 3, 67 (2020).
Moran, Y. et al. Neurotoxin localization to ectodermal gland cells uncovers an alternative mechanism of venom delivery in sea anemone. Proc. R. Soc. B 279, 1351–1358 (2012).
Columbus-Shenkar, Y. Y. et al. Dynamics of venom composition across a complex life cycle. Elife 7, e35014 (2018).
Macrander, J., Broe, M. & Daly, M. Tissue-specific venom composition and differential gene expression in sea anemone. Genome. Biol. Evol. 8, 2358–2375 (2016).
Grajales, A. & Rodríguez, E. Elucidating the evolutionary relationship of the Aiptasiidae, a widespread cnidarian-dinoflagellate model system (Cnidaria: Anthozoa: Actiniaria: Metridioidea). Mol. Phylogenet. Evol. 94, 252–263 (2016).
Briones-Fourzán, P., Pérez-Ortiz, M., Negrete-Soto, F., Barradas-Ortiz, C. & Lozano-Álvarez, E. Ecological traits of Caribbean Sea anemones and symbiotic crustaceans. Mar. Ecol. Prog. Ser. 470, 55–68 (2012).
González-Muñoz, R., Nuno, S., Sánchez-Rodríguez, J., Rodríguez, E. & Segura-Puertas, L. First inventory of sea anemones (Cnidaria: Actinaria) of the Mexican Caribbean. Zootaxa 3556, 1–38 (2012).
O’Reilly, E. E. & Chadwick, N. E. Population dynamics of corkscrew sea anemones Bartholomea annulata in the Florida Keys. Mar. Ecol. Prog. Ser. 567, 109–123 (2017).
Calgren, O. A survey of the Ptychodactiaria, Corallimorpharia and Actinaria. Kungl. Svenska Vetenskapsakad. Handl. 3, 1–121 (1949).
Sánchez-Rodríguez, J., Zugasti, A., Santamaría, A., Galván-Arzate, S. & Segura-Puertas, L. Isolation, partial purification and characterization of active polypeptide from the sea anemone Bartholomea annulata. Basic Clin. Pharmacol. Toxicol. 99, 116–121 (2006).
Morales-Landa, J. L. et al. Antimicrobial, antiprotozoal and toxic activities of cnidarian extracts from the Mexican Caribbean Sea. Pharm. Biol. 45, 37–43 (2007).
Nesher, N. et al. AdE-1, a new inotropic Na+ channel toxin from Aiptasia diaphana, is similar to, yet distinct from, known anemone Na+ channel toxins. Biochem. J. 451, 81–90 (2013).
Nesher, N., Zlotkin, E. & Hochner, B. The sea anemone toxin AdE-1 modifies both sodium and potassium currents of rat cardiomyocytes. Biochem. J. 461, 51–59 (2014).
Lazcano-Pérez, F., Arellano, R. O., Garay, E., Arreguín-Espinosa, R. & Sánchez-Rodríguez, J. Electrophysiological activity of a neurotoxic fraction from the venom of box jellyfish Carybdea marsupialis. Comp. Biochem. Physiol. C Toxicol. Pharmacol. 191, 177–182 (2017).
Bernáldez, J. et al. Electrophysiological characterization of a novel small peptide from the venom of Conus californicus that targets voltage-gated neuronal Ca2+ channels. Toxicon 57, 60–67 (2011).
Parker, I., Sumikawa, K. & Miledi, R. Activation of a common effector system by different brain neurotransmitter receptors in Xenopus Oocytes. Proc. R. Soc. Lond. B 231, 37–45 (1987).
Miledi, R., Parker, I. & Sumikawa, K. Transplanting receptors from brains into oocytes. In Fidia Research Foundation Neuroscience Award Lectures, 57–90 (Raven Press, 1989).
Arellano, R. O., Robles-Martínez, L., Serrano-Flores, B., Vázquez-Cuevas, F. & Garay, E. Agonist-activated Ca2+ influx and Ca2+-dependent Cl− channels in Xenopus ovarian follicular cells: Functional heterogeneity within the cell monolayer. J. Cell. Physiol. 227, 3457–3470 (2012).
Arellano, R. O. & Miledi, R. Novel Cl- currents elicited by follicle stimulating hormone and acetylcholine in follicle-enclosed Xenopus oocytes. J. Gen. Physiol. 102, 833–857 (1993).
Arellano, R. O., Woodward, R. M. & Miledi, R. Ion channels and membrane receptors in follicle-enclosed Xenopus oocytes. In Ion Channels Vol. 4 (ed. Narahashi, T.) 203–259 (Springer, 1996).
Gundersen, C. B., Miledi, R. & Parker, I. Voltage-operated channels induced by foreign messenger RNA in Xenopus oocytes. Proc. R. Soc. Lond. B 220, 131–140 (1983).
Gundersen, C. B., Miledi, R. & Parker, I. Messenger RNA from human brain induces drug- and voltage-operated channels in Xenopus oocytes. Nature 308, 421–424 (1984).
Bloom, D. A., Burnett, J. W. & Alderslade, P. Partial purification of box jellyfish (Chironex fleckeri) nematocyst venom isolated at the beachside. Toxicon 36, 1075–1085 (1998).
Narahashi, T. Chemicals as tools in the study of excitable membranes. Physiol. Rev. 54, 813–889 (1974).
Narahashi, T. Pharmacology of tetrodotoxin. J. Toxicol. Toxin rev. 20, 67–84 (2001).
Lee, C. H. & Ruben, P. C. Interaction between voltage-gated sodium channels and the neurotoxin, tetrodotoxin. Channels 2, 407–412 (2008).
Ordaz, P. R. et al. GABAA receptors expressed in oligodendrocytes cultured from the neonatal rat contain α3 and γ1 subunits and present differential functional and pharmacological properties. Mol. Pharmacol. 99, 133–146 (2021).
Martínez-Torres, A. & Miledi, R. Expression of γ-aminobutyric acid ρ1 and ρ1Δ450 as gene fusion with the green fluorescent protein. Proc. Natl. Acad. Sci. U.S.A. 98, 1947–1951 (2001).
Lazcano-Pérez, F., Hernández-Guzmán, U., Sánchez-Rodríguez, J. & Arreguín-Espinosa, R. Cnidarian neurotoxic peptides affecting central nervous system targets. Cent. Nerv. Syst. Agents Med. Chem. 16, 173–182 (2016).
Norton, R. S. Structures of sea anemone toxins. Toxicon 54, 1075–1088 (2009).
Iglesias-Prieto, R., Govin, N. S. & Trench, R. K. Isolation and characterization of three membrane-bound chlorophyll-protein complexes from four dinoflagellate species. Philos. Trans. R. Soc. Lond. B 340, 381–392 (1993).
Béress, R., Béress, L. & Wunderer, G. Purification and characterisation of four polypeptides with neurotoxic activity from Condylactis aurantiaca. Hope-Seyler’s Z Physiol. Chem. 357, 409–414 (1976).
Rodríguez, A. A. et al. Peptide fingerprint of the neurotoxic fractions isolated from the secretions of sea anemone Stichodactyla helianthus and Bunodosoma granulifera. New members of the APETx-like family identified by a 454 pyrosequencing approach. Peptides 34, 26–38 (2012).
Moran, Y., Gordon, D. & Gurevitz, M. Sea anemone toxins affecting voltage-gated sodium channels—Molecular and evolutionary features. Toxicon 54, 1089–1101 (2009).
Madio, B., King, G. E. & Undheim, E. A. B. Sea anemone toxins: A structural overview. Mar. Drugs 17, 325 (2019).
D’Ambra, I. & Lauritano, C. A. Review of toxins from Cnidaria. Mar. Drugs 18, 507 (2020).
Aneiros, A. et al. A potassium channel toxin from the secretion of the sea anemone Bunodosoma granulifera. Isolation, amino acid sequence and biological activity. Biochim. Biophys. Acta 1157, 86–92 (1993).
Ständker, L. et al. A new toxin from the sea anemone Condylactis gigantea with effect on sodium channel inactivation. Toxicon 48, 211–220 (2006).
Zaharenko, A. J. et al. Characterization of selectivity and pharmacophores of type 1 sea anemone toxins by screening seven Nav sodium channel isoforms. Peptides 34, 158–167 (2012).
Liao, Q., Feng, Y., Yang, B. & Lee, S.-Y. Cnidarian peptide neurotoxins: A new source of various ion channel modulators or blockers against central nervous system disease. Drug Discov. Today 24, 189–197 (2019).
Catteral, W. A. & Béress, L. Sea anemone toxin and scorpion toxin share a common receptor site associated with the action potential sodium ionophore. J. Biol. Chem. 253, 7393–7396 (1978).
Ahern, C. A., Payandeh, J., Bosman, F. & Chanda, B. The hitchhiker’s guide to the voltage-gated sodium channel galaxy. J. Gen. Physiol. 147, 1–24 (2016).
Ravindran, V. S., Kannan, L. & Venkateshvaran, K. Biological activity of sea anemone proteins: I. Toxicity and histopathology. Indian J. Exp. Biol. 47, 1225–1232 (2010).
Israel, M. R., Tay, B., Deuis, J. R. & Vetter, I. Sodium channels and venom peptide pharmacology. Adv. Pharmacol. 127, 87–108 (2017).
Dudley, S. C. et al. μ-Conotoxin GIIIA interactions with the voltage-gated Na+ channel predict a clockwise arrangement of the domains. J. Gen. Physiol. 116, 679–689 (2000).
Kubota, T., Dang, B., Carvalho-de-Souza, J. L., Correa, A. M. & Benzanilla, F. Nav channel binder containing a specific conjugation-site based on a low toxicity β-scorpion toxin. Sci. Rep. 7, 16329 (2017).
Hernández-Plata, E. et al. Overexpression of Nav 1.6 channels is associated with the invasion capacity of human cervical cancer. Int. J. Cancer 130, 2013–2023 (2012).
Israel, M. R., Morgan, M., Tay, B. & Deuis, J. R. Toxins as tools: Fingerprinting neuronal pharmacology. Neurosci. Lett. 679, 4–14 (2018).
Kozlov, S. Animal toxins for channelopathy treatment. Neuropharmacology 132, 83–97 (2018).
Jayathilake, J. M. N. J. & Gunathilake, K. V. K. Cnidarian toxins: Recent evidences for potential therapeutic uses. Eur. Zool. J. 87(1), 708–713 (2020).
Johnston, G. A. R. Muscimol as an ionotropic GABA receptor agonist. Neurochem. Res. 39, 1942–1947 (2014).
Kudryavtsev, D. S. et al. Neurotoxins from snake venoms and α-conotoxin ImI inhibit functionally active ionotropic γ-aminobutyric acid (GABA) receptors. J. Biol. Chem. 290, 22747–22758 (2015).
Scappaticci, A. A. & Kass-Simon, G. NMDA and GABAB receptors are involved in controlling nematocyst discharge in hydra. Comp. Biochem. Physiol. A 150, 415–422 (2008).
Chomczynski, P. & Sacchi, N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal. Biochem. 162, 156–159 (1987).
Dumont, J. N. Oogenesis in Xenopus laevis (Daudin). I. Stages of oocyte development in laboratory maintained animals. J. Morphol. 136, 153–179 (1972).
Pérez-Samartín, A. et al. Inwardly rectifying K+ currents in cultured olidendrocytes from rat optic nerve are insensitive to pH. Neurochem. Res. 42, 2443–2455 (2017).
Cisneros-Mejorado, A. et al. Demyelination-remyelination of the rat caudal cerebellar peduncle evaluated with magnetic resonance imaging. Neuroscience 439, 255–267 (2020).
Barres, B. A. et al. Cell death and control cell survival in the oligodendrocyte lineage. Cell 70, 31–46 (1992).
Arellano, R. O. et al. Axon-to-glia interaction regulates GABAA receptor expression in oligodendrocytes. Mol. Pharmacol. 89, 63–74 (2016).
Restano-Cassulini, R., Garcia, W., Paniagua-Solís, J. E. & Possani, L. D. Antivenom evaluation by electrophysiological analysis. Toxins 9, 74 (2017).
Acknowledgements
The authors are grateful to M.Sc. Sergio Wendoline, M.Sc. Amanda Pérez, M.Sc. Edgar Escalante and Mr. Amaury Mendoza for their help in B. annulata collection, and to Mr. Yamir Sánchez for B. annulata photographs. Dr. Arisaí C. Hernández-Sámano, Dr. Raúl Castillo-Medina, Exp. Biol. Andrés Falcón, M.Sc. Laura Celis, M.Sc. Aleida Flores-Pérez and C. Luisa Fernanda Cruz for their invaluable technical support. Dr. Roberto Arreguín-Espinosa and M.Sc. Lucero Rios Ruiz from Instituto de Química, UNAM, for their help with mass spectrometry analysis. This study was supported by Grants from PAPIIT-UNAM-México No. IN217420 to J.S.-R., No. IN203519 to R.O.A., No. IN208617 to M.B.A., and CONACyT No. 1771 to A.C.-M. (Cátedras-CONACYT Researcher). A.C.-C. is a doctoral student from Posgrado de Ciencias del Mar y Limnología at Universidad Nacional Autónoma de México (UNAM) and received CONACyT No. 517866 and PAPIIT No. IN217420 scholarships.
Author information
Authors and Affiliations
Contributions
A.C.-C., J.S.-R., R.O.A. and M.B.A. participated in research design. A.C.-C., J.S.-R., R.O.A., E.G., and A.C.-M. conducted experiments. A.C.-C., J.S.-R., R.O.A., E.G., A.C.-M., M.B.A. and F.L.-P. wrote or contributed to the writing of the manuscript. All authors analyzed the results and critically commented on the manuscript.
Corresponding authors
Ethics declarations
Competing interests
The authors declare no competing interests.
Additional information
Publisher's note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Supplementary Information
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.
About this article
Cite this article
Colom-Casasnovas, A., Garay, E., Cisneros-Mejorado, A. et al. Sea anemone Bartholomea annulata venom inhibits voltage-gated Na+ channels and activates GABAA receptors from mammals. Sci Rep 12, 5352 (2022). https://doi.org/10.1038/s41598-022-09339-x
Received:
Accepted:
Published:
DOI: https://doi.org/10.1038/s41598-022-09339-x
Comments
By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.